NCT01279616: A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease |
|
|
| Terminated | 2 | 8 | US | Fludarabine monophosphate, Rituximab, Rituxan, Busulfan, busulfex, ATG, Thymoglobulin, Cyclophosphamide, Cytoxan, Mycophenolate mofetil, MMF, Cell-cept., Tacrolimus, FK-506 | Nationwide Children's Hospital | Sickle Cell Disease | 01/15 | 01/15 | | |
